{"ticker": {"uuid": "a0ce0b8e-06c8-4e22-bdae-383b4450f052", "symbol": "JAGSNPHARM", "name": "Jagsonpal Pharmaceuticals Limited", "exchange": "NSI", "country": "IN", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic"}, "articles": [{"title": "Jagsonpal Pharma rallies 14% on acquisition update; time to book profit?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Business Standard", "published_at": "2026-06-30T07:00:00+00:00", "published_display": "30 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Jagsonpal to acquire 85% stake in Aequitas for \u20b920.8 crore", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0wFBVV95cUxPY21XcmtsWlRENEp3UjdQTTRaYjRJQXdGcGE1NXZ4NC1ET04tWThuLW55UWxqcXFlQ19kLVFnUy1mQ1l1R21KeGF1ZGpxZHRNNzZ3bndWbngxdWVTQk9ZcUt5dVo1MDNkUElPTm5tNnJPTlRITERKSWk4NHV5VjRCeC1BbUIxdzN3NjJqWkhNVjB1Z2lNYzUtUnBXYk9Kak5qdlVlSzBPX0pxYnlmTTNTTkxxR3RfZ2FOU3BjS3VBTlFKVGJsYUk0b3dIazNBTEJPV2Y0?oc=5", "source_name": "scanx.trade", "published_at": "2026-06-29T07:00:00+00:00", "published_display": "29 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Jagsonpal Pharmaceuticals extinguishes 16 lakh shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxNWlV4TEpwdmpCYXZDdlNtZWI2V2hLU2FYVER1WnYzWDdlYTRQZXkxZ3pDZml0ZVRSVDJ2MjQ3ZzdWXzE5Q0lkRjNjTVR1d0pMdDd3SHBSOE1xS1pNZmppQTJDd3V3VGdrNVZWalh6U3Mza0R2MHM1bTBabjFrd2s1RDB4eHdDZ21uUlFfeDRWWUNWRTBFRU1jT2x3V25ldG9yeVVrWGNyNUNEZ1Z1bXVz?oc=5", "source_name": "scanx.trade", "published_at": "2026-06-02T07:00:00+00:00", "published_display": "02 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Jagsonpal concludes \u20b940 crore buyback at \u20b9250 per share", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxQbnlYZDAwTmRYNGZtYlZUSDh6TFpESXd3UFFfZU5YSi1jQWJLelE5eklJQk1QZlEwdzA0UUgtbUhBVHNTdVl2dE93aGU0SGJpMExJaERLTkNfQUhYWllpOGxYbkJ6UWZiSnNDNFJxb1dONEx3a1FDQzdTOE96THRzYVJ1ZEo5V3JsRlhFNnMxazlzV0xxRkJtWlhDT2RMWDVzaGZsckpNaEFiWWdEM0E?oc=5", "source_name": "scanx.trade", "published_at": "2026-05-25T07:00:00+00:00", "published_display": "25 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hikma Pharmaceuticals PLC stock (GB00B128J450): Dividend hike and $250M buyback", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxNX2ZfWkxLZDAyQUZNRU55RXhPVHI4dlZrTVVuc3RlV01XV0Jqd21vSDdYU0l3QkJOejBicXhjRXhQcmpkZHlVQ3BsRFE5ZFFxbFV3MWgtLUpndEZKTm1vbTAwaGlYMHEzWVVjNDVUYjFpM1hJS0NRTjdCc3pOeG9VNlg0QThScXpuV3lYNi0xY2NXMnkwdkFMYU8xYWU0WTIyaVdESzRVV2wxaThRazh6bTZCV1RPMWpJWW0tZy1qQUJVNjh6?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Jagsonpal Buyback Opens May 8, 2026; Letter of Offer Dispatched", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxNVDhydTlPb3lzVjdwdDRhREZObWY0OWpuUE5kMDZlWXotME1nVEJjbl9XUGUtRHhKWHZnaG51TDdvdjEyUlptQmRBOFZkRzJVUTdaUm1RMV96VEthLTRCS1F4OGVfWVR4SmRUb3k0cjh2aVhIQklZT01uVHlDbTR0OVhrS2ZMQXJ6czhfYkZvV3JiZ3BSa1VpX3JhZU95bElJWW9wWHRiVVJMWjF6UGE4V1R1WmxKbWh2ZDc5WFFNb1RtdzI3VklFM05ZVFhXU0VPLXc?oc=5", "source_name": "scanx.trade", "published_at": "2026-05-06T07:00:00+00:00", "published_display": "06 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Jagsonpal Pharmaceuticals Q4 FY26: 200% Dividend, INR40 Crore Buyback", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1AFBVV95cUxQOFlxcmwwOV9WZnhjT2p0MUkzWC1FakxZUE5vcXZUazNrODl5bnVDeTlHQTlfWV9BOFhHam9QRHlKYkRZZGw5d2hIekhWSU1kZXRTYjRUeGpXSGI1Q01wMV9GQzNQano3eE8xVTNNZGEwSFNZRkk5bDJISXFiTGFEVnliWkdXUFItdVJqaTU3SGRBMzdrcHpZTndNSTJGREdhcTI2Z29aZVZsYTJNUGFURGdBczhyQWFGcTRNWlQ3TDZFSXdSNy02MVotWVYydGxhbkFlWQ?oc=5", "source_name": "scanx.trade", "published_at": "2026-05-04T07:00:00+00:00", "published_display": "04 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Jagsonpal Pharmaceuticals Publishes Postal Ballot Notice for \u20b940 Crore Buyback", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2gFBVV95cUxQeG01aGZ2a0dVb3RMcGJVRXMzX1dVOEtRY184SHVUcEVES2NteG5uMU1BampnUmlPd2pxZlROa2FlRDBlQjVMV0YzNWdyNmV5ZWgzM3BKTWl4cVo4YlJoN0s3MTRXSXdpQ0F3dzRybGd2dVV3WGNDdEFSeEZnOElpR0V4QmFITkhwYXQtVngwS2RJN0VkSFpWU29taGVlN2VmMEtZRk40WGtoTF92djlGbkxCZW41VEZOLXp4aTU1dmx0WTJLV0pXbHMyb0RwUFhVVUtqQURzNUtyQQ?oc=5", "source_name": "scanx.trade", "published_at": "2026-03-26T07:00:00+00:00", "published_display": "26 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Jagsonpal Pharma surges 12% after buyback plan of up to 16 lakh shares at \u20b9250 each", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "CNBC TV18", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Jagsonpal Pharmaceuticals To Consider Share Buyback", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxNSGN5UHZwZDgyY0RQU2NZYnhzR1JTSVhFdnpGVzh1NkFsTXRyd0F5V2lqRHdXTE9SOHd3b0ZLZXB0c2kzajVLVDI2WDRaYTFBT0I4VlE3dERYRHBPUTBuVU00d1ZkdnBwakdudkhfVjNMWFM1NlV0LW9icHZCNEM4Z3g1Rnp1RmRnMXUwZ1ZBcWNUaXRpU3ZwdXJQN2VYRDVnQnloTEJRdk80aS15R0xOT3hGMTl2RnN5Uk8tWnN3?oc=5", "source_name": "TradingView", "published_at": "2026-03-09T07:00:00+00:00", "published_display": "09 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 62, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "We Think Shareholders Should Be Aware Of Some Factors Beyond Jagsonpal Pharmaceuticals' (NSE:JAGSNPHARM) Profit", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-11-13T08:00:00+00:00", "published_display": "13 Nov 2025 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "We Take A Look At Why Jagsonpal Pharmaceuticals Limited's (NSE:JAGSNPHARM) CEO Compensation Is Well Earned", "summary": "", "url": "https://news.google.com/rss/articles/CBMi_gFBVV95cUxPcGcwU2RoM0pIZ3lsSXNTQzlQanAyMTBGenZ2ZWozM2pJTDQ4T3dEUmxadXMtN3hVazB5QWxTeVIzc2I3NndQUm1RSzBBay1ydTUyMmprYzJtRmdRclRFTnE3SWJyR1VBeFJheHJMc2ppV2ZxWkN4MEtWVzZER2tUazBGWHRpc25qWDJCcUtxT0Jsb210N2hNdURGUGNLMzlzbnRraUlwUm5YZ3BuakxaMjNmNFB0Zm8wTFpIb0pWU05kU0UyZVFhZVAtNFNWb3ljY2dWczVHRVdlbEYxRlk1OGpBNno2RVB3eFJvSHFUZWIxOFFwbGxCcnpSNEpTQdIBgwJBVV95cUxORlpONS1feHVfTS1wV1NKcG5zdmU1aFBOMDNJUmxBZG5rSWRueW14a0Q5VlF0UzlFaktEOEk3RkFtZnVSdWx1aDBrZnFLNE5UTXFIVG0xTTlyelpRbUJDUnY4SmVWbkt5aEZlS0ZtLTZBWVNuN1BQV2VKQVZqdHl4cFV3aGVwQ3NkM29kYVZXTWpKR291N3hlczNxNVZtQmVvbmhteWFLRnl5X3pzLWlDbXNTcmNRVE95NjlhWk9hNTZsUnhrSDdMa2pZRTFyUW45WmJKcjRtZ0t6UGxha0d4WXpPa2hVNUs5bXVUQzQySlhIM0liTVNlSWQ4R3g3cVBaRWNz?oc=5", "source_name": "simplywall.st", "published_at": "2025-09-18T07:00:00+00:00", "published_display": "18 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Market Might Still Lack Some Conviction On Jagsonpal Pharmaceuticals Limited (NSE:JAGSNPHARM) Even After 33% Share Price Boost", "summary": "", "url": "https://news.google.com/rss/articles/CBMi_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?oc=5", "source_name": "simplywall.st", "published_at": "2025-07-29T07:00:00+00:00", "published_display": "29 Jul 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Jagsonpal Pharmaceuticals 1:2.5 stock split record date tomorrow. Do you own?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "The Economic Times", "published_at": "2025-01-07T08:00:00+00:00", "published_display": "07 Jan 2025 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Jagsonpal Pharmaceuticals Ltd. Share Price Today | Jagsonpal Pharma Live NSE/BSE", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxPX2NSUjJuNzNpdS16aXNfVTB2WnZDbTR3WHg1Umw1NUVoRm1JTnJGRFYwUm1zT2Q3a1Y1SXdnTHZ4QTFMUGZxWXR4dUYzcWtUVGJhQ0x6YlFLTGYtMWhPY2FUaVd6TG9TdEQ3bF83TW9OcHQ3MHRCaDFFZjVVaDJXRzZVS1J2dw?oc=5", "source_name": "Value Research", "published_at": "2022-03-24T19:13:22+00:00", "published_display": "24 Mar 2022 19:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Convergent Funds to buy stake in Jagsonpal Pharmaceuticals in first control bet", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxOUUtndE9FeXBGdjRzcm0yZ1oyUThVMVQtQjkyb3A1NzExaWxtRFIwY1oySWxhOG5SNGV2T3FiT0h3cFhyMFJHU2NiVElUSVA3eG9OUkRLVmk5ZHRFMTB2NlVhS282Q2ZjNkp1VUVTVFNibHAwWFVWeUFNcTB1aVJsWWYwblpaV2JYR2tVX3pfcFJ3U091bUdVNGRaWQ?oc=5", "source_name": "VCCircle", "published_at": "2022-02-21T08:00:00+00:00", "published_display": "21 Feb 2022 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Jagsonpal Pharma rallies 14% on acquisition update; time to book profit?", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2gFBVV95cUxOVlJQcGRFTUp0NHpfdlpZSl9mNDc4cnBxUkRsWVplb3ZCeXRfbTdaNVFRRWU5S2NUZWxMTzJFZVFfOVAyNEFOdkFtLXU2dmZJdDZZWUstaFNRQlNHaUZ4X0ZsNHpNWXZfWkNsd0liV1BsYk44UEd3aWFwZ3NpR0EtSnVzOG9wRzNxOXhJMUlTWUxwTDFicWlMOVI3cGV4Z2xVb3VraEJFbVcxUTJvcE03TDNSV19aSzU2c09FR3N6eENPdWJfbzBlbDVRX0pmcFI2Nm9iMmNiV1hoZ9IB3wFBVV95cUxNbE1KVVZIYzEzTzlPNFF0SmxBQXV3SVE2bHcySlk0UVYweUVPQUFSaFNmb2xydlUtdE1hTGU5aWNIdHowLV85eUpxYkVGVVN5UVNTcnlJVDZkUnkxb2xLeTZJd2QwRGl6LVl3Nmd0NHp5UVN5N2JGdWZhQ0JjSHFxUG9pTE51MU9rV0w2LVNwMHlUMWZSNkRuQ3M4REhvdUszVG05U0Vac1RNWXZWZ1k2VmdaY09ENTVudnZXMnl3VTlTU2FmMS1fM2pyR016T3V6eFlIM3BqVGlsOG11TnZZ?oc=5", "source_name": "Business Standard", "published_at": "2026-06-30T07:00:00+00:00", "published_display": "30 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Jagsonpal to acquire 85% stake in Aequitas for \u20b920.8 crore", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0wFBVV95cUxPY21XcmtsWlRENEp3UjdQTTRaYjRJQXdGcGE1NXZ4NC1ET04tWThuLW55UWxqcXFlQ19kLVFnUy1mQ1l1R21KeGF1ZGpxZHRNNzZ3bndWbngxdWVTQk9ZcUt5dVo1MDNkUElPTm5tNnJPTlRITERKSWk4NHV5VjRCeC1BbUIxdzN3NjJqWkhNVjB1Z2lNYzUtUnBXYk9Kak5qdlVlSzBPX0pxYnlmTTNTTkxxR3RfZ2FOU3BjS3VBTlFKVGJsYUk0b3dIazNBTEJPV2Y0?oc=5", "source_name": "scanx.trade", "published_at": "2026-06-29T07:00:00+00:00", "published_display": "29 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Jagsonpal Pharmaceuticals extinguishes 16 lakh shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxNWlV4TEpwdmpCYXZDdlNtZWI2V2hLU2FYVER1WnYzWDdlYTRQZXkxZ3pDZml0ZVRSVDJ2MjQ3ZzdWXzE5Q0lkRjNjTVR1d0pMdDd3SHBSOE1xS1pNZmppQTJDd3V3VGdrNVZWalh6U3Mza0R2MHM1bTBabjFrd2s1RDB4eHdDZ21uUlFfeDRWWUNWRTBFRU1jT2x3V25ldG9yeVVrWGNyNUNEZ1Z1bXVz?oc=5", "source_name": "scanx.trade", "published_at": "2026-06-02T07:00:00+00:00", "published_display": "02 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Jagsonpal concludes \u20b940 crore buyback at \u20b9250 per share", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxQbnlYZDAwTmRYNGZtYlZUSDh6TFpESXd3UFFfZU5YSi1jQWJLelE5eklJQk1QZlEwdzA0UUgtbUhBVHNTdVl2dE93aGU0SGJpMExJaERLTkNfQUhYWllpOGxYbkJ6UWZiSnNDNFJxb1dONEx3a1FDQzdTOE96THRzYVJ1ZEo5V3JsRlhFNnMxazlzV0xxRkJtWlhDT2RMWDVzaGZsckpNaEFiWWdEM0E?oc=5", "source_name": "scanx.trade", "published_at": "2026-05-25T07:00:00+00:00", "published_display": "25 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hikma Pharmaceuticals PLC stock (GB00B128J450): Dividend hike and $250M buyback", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxNX2ZfWkxLZDAyQUZNRU55RXhPVHI4dlZrTVVuc3RlV01XV0Jqd21vSDdYU0l3QkJOejBicXhjRXhQcmpkZHlVQ3BsRFE5ZFFxbFV3MWgtLUpndEZKTm1vbTAwaGlYMHEzWVVjNDVUYjFpM1hJS0NRTjdCc3pOeG9VNlg0QThScXpuV3lYNi0xY2NXMnkwdkFMYU8xYWU0WTIyaVdESzRVV2wxaThRazh6bTZCV1RPMWpJWW0tZy1qQUJVNjh6?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Jagsonpal Buyback Opens May 8, 2026; Letter of Offer Dispatched", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxNVDhydTlPb3lzVjdwdDRhREZObWY0OWpuUE5kMDZlWXotME1nVEJjbl9XUGUtRHhKWHZnaG51TDdvdjEyUlptQmRBOFZkRzJVUTdaUm1RMV96VEthLTRCS1F4OGVfWVR4SmRUb3k0cjh2aVhIQklZT01uVHlDbTR0OVhrS2ZMQXJ6czhfYkZvV3JiZ3BSa1VpX3JhZU95bElJWW9wWHRiVVJMWjF6UGE4V1R1WmxKbWh2ZDc5WFFNb1RtdzI3VklFM05ZVFhXU0VPLXc?oc=5", "source_name": "scanx.trade", "published_at": "2026-05-06T07:00:00+00:00", "published_display": "06 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Jagsonpal Pharmaceuticals Q4 FY26: 200% Dividend, INR40 Crore Buyback", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1AFBVV95cUxQOFlxcmwwOV9WZnhjT2p0MUkzWC1FakxZUE5vcXZUazNrODl5bnVDeTlHQTlfWV9BOFhHam9QRHlKYkRZZGw5d2hIekhWSU1kZXRTYjRUeGpXSGI1Q01wMV9GQzNQano3eE8xVTNNZGEwSFNZRkk5bDJISXFiTGFEVnliWkdXUFItdVJqaTU3SGRBMzdrcHpZTndNSTJGREdhcTI2Z29aZVZsYTJNUGFURGdBczhyQWFGcTRNWlQ3TDZFSXdSNy02MVotWVYydGxhbkFlWQ?oc=5", "source_name": "scanx.trade", "published_at": "2026-05-04T07:00:00+00:00", "published_display": "04 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Jagsonpal Pharmaceuticals Publishes Postal Ballot Notice for \u20b940 Crore Buyback", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2gFBVV95cUxQeG01aGZ2a0dVb3RMcGJVRXMzX1dVOEtRY184SHVUcEVES2NteG5uMU1BampnUmlPd2pxZlROa2FlRDBlQjVMV0YzNWdyNmV5ZWgzM3BKTWl4cVo4YlJoN0s3MTRXSXdpQ0F3dzRybGd2dVV3WGNDdEFSeEZnOElpR0V4QmFITkhwYXQtVngwS2RJN0VkSFpWU29taGVlN2VmMEtZRk40WGtoTF92djlGbkxCZW41VEZOLXp4aTU1dmx0WTJLV0pXbHMyb0RwUFhVVUtqQURzNUtyQQ?oc=5", "source_name": "scanx.trade", "published_at": "2026-03-26T07:00:00+00:00", "published_display": "26 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Jagsonpal Pharma surges 12% after buyback plan of up to 16 lakh shares at \u20b9250 each", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "CNBC TV18", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Jagsonpal Pharmaceuticals To Consider Share Buyback", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxNSGN5UHZwZDgyY0RQU2NZYnhzR1JTSVhFdnpGVzh1NkFsTXRyd0F5V2lqRHdXTE9SOHd3b0ZLZXB0c2kzajVLVDI2WDRaYTFBT0I4VlE3dERYRHBPUTBuVU00d1ZkdnBwakdudkhfVjNMWFM1NlV0LW9icHZCNEM4Z3g1Rnp1RmRnMXUwZ1ZBcWNUaXRpU3ZwdXJQN2VYRDVnQnloTEJRdk80aS15R0xOT3hGMTl2RnN5Uk8tWnN3?oc=5", "source_name": "TradingView", "published_at": "2026-03-09T07:00:00+00:00", "published_display": "09 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 62, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "We Think Shareholders Should Be Aware Of Some Factors Beyond Jagsonpal Pharmaceuticals' (NSE:JAGSNPHARM) Profit", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-11-13T08:00:00+00:00", "published_display": "13 Nov 2025 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "We Take A Look At Why Jagsonpal Pharmaceuticals Limited's (NSE:JAGSNPHARM) CEO Compensation Is Well Earned", "summary": "", "url": "https://news.google.com/rss/articles/CBMi_gFBVV95cUxPcGcwU2RoM0pIZ3lsSXNTQzlQanAyMTBGenZ2ZWozM2pJTDQ4T3dEUmxadXMtN3hVazB5QWxTeVIzc2I3NndQUm1RSzBBay1ydTUyMmprYzJtRmdRclRFTnE3SWJyR1VBeFJheHJMc2ppV2ZxWkN4MEtWVzZER2tUazBGWHRpc25qWDJCcUtxT0Jsb210N2hNdURGUGNLMzlzbnRraUlwUm5YZ3BuakxaMjNmNFB0Zm8wTFpIb0pWU05kU0UyZVFhZVAtNFNWb3ljY2dWczVHRVdlbEYxRlk1OGpBNno2RVB3eFJvSHFUZWIxOFFwbGxCcnpSNEpTQdIBgwJBVV95cUxORlpONS1feHVfTS1wV1NKcG5zdmU1aFBOMDNJUmxBZG5rSWRueW14a0Q5VlF0UzlFaktEOEk3RkFtZnVSdWx1aDBrZnFLNE5UTXFIVG0xTTlyelpRbUJDUnY4SmVWbkt5aEZlS0ZtLTZBWVNuN1BQV2VKQVZqdHl4cFV3aGVwQ3NkM29kYVZXTWpKR291N3hlczNxNVZtQmVvbmhteWFLRnl5X3pzLWlDbXNTcmNRVE95NjlhWk9hNTZsUnhrSDdMa2pZRTFyUW45WmJKcjRtZ0t6UGxha0d4WXpPa2hVNUs5bXVUQzQySlhIM0liTVNlSWQ4R3g3cVBaRWNz?oc=5", "source_name": "simplywall.st", "published_at": "2025-09-18T07:00:00+00:00", "published_display": "18 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Market Might Still Lack Some Conviction On Jagsonpal Pharmaceuticals Limited (NSE:JAGSNPHARM) Even After 33% Share Price Boost", "summary": "", "url": "https://news.google.com/rss/articles/CBMi_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?oc=5", "source_name": "simplywall.st", "published_at": "2025-07-29T07:00:00+00:00", "published_display": "29 Jul 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Jagsonpal Pharmaceuticals 1:2.5 stock split record date tomorrow. Do you own?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "The Economic Times", "published_at": "2025-01-07T08:00:00+00:00", "published_display": "07 Jan 2025 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Jagsonpal Pharmaceuticals Ltd. Share Price Today | Jagsonpal Pharma Live NSE/BSE", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxPX2NSUjJuNzNpdS16aXNfVTB2WnZDbTR3WHg1Umw1NUVoRm1JTnJGRFYwUm1zT2Q3a1Y1SXdnTHZ4QTFMUGZxWXR4dUYzcWtUVGJhQ0x6YlFLTGYtMWhPY2FUaVd6TG9TdEQ3bF83TW9OcHQ3MHRCaDFFZjVVaDJXRzZVS1J2dw?oc=5", "source_name": "Value Research", "published_at": "2022-03-24T19:13:22+00:00", "published_display": "24 Mar 2022 19:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Convergent Funds to buy stake in Jagsonpal Pharmaceuticals in first control bet", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxOUUtndE9FeXBGdjRzcm0yZ1oyUThVMVQtQjkyb3A1NzExaWxtRFIwY1oySWxhOG5SNGV2T3FiT0h3cFhyMFJHU2NiVElUSVA3eG9OUkRLVmk5ZHRFMTB2NlVhS282Q2ZjNkp1VUVTVFNibHAwWFVWeUFNcTB1aVJsWWYwblpaV2JYR2tVX3pfcFJ3U091bUdVNGRaWQ?oc=5", "source_name": "VCCircle", "published_at": "2022-02-21T08:00:00+00:00", "published_display": "21 Feb 2022 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 62, "total_relevant": 16, "sentiment_summary": {"positive": 6, "negative": 0, "neutral": 10, "score": 57, "total": 16, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "capital_return", "primary_label": "Capital return", "confidence": 75, "events": [{"event": "capital_return", "label": "Capital return", "weight": 4.2, "count": 7}, {"event": "general", "label": "Market update", "weight": 3.1, "count": 5}, {"event": "deals", "label": "Deals and strategy", "weight": 2.0, "count": 3}, {"event": "earnings", "label": "Earnings", "weight": 0.55, "count": 1}], "positive_events": 6, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 232.77, "latest_week": "2026-07-10", "one_week_move": -1.6, "four_week_move": 10.1, "twelve_week_move": 21.3, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 1.424135, "market_dynamics_buy_signal": false, "relative_strength": 13.914001, "fair_value_gap": 23.6, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "undecided", "expectation_probability": 51.4572, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "-1.6% over one week, +10.1% over four weeks, trend active, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 65, "badges": [], "opportunities": [], "risks": [], "event_label": "Capital return", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "scanx.trade", "count": 6}, {"label": "simplywall.st", "count": 3}, {"label": "Business Standard", "count": 1}, {"label": "ad-hoc-news.de", "count": 1}, {"label": "CNBC TV18", "count": 1}, {"label": "TradingView", "count": 1}, {"label": "The Economic Times", "count": 1}, {"label": "Value Research", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 16}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Capital return", "count": 7}, {"label": "Market update", "count": 5}, {"label": "Deals and strategy", "count": 3}, {"label": "Earnings", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "57/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Capital return", "tone": "neutral", "text": "75/100 classification confidence."}, {"label": "Company focus", "value": "16", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "3", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "-1.6% over one week, +10.1% over four weeks, trend active, and near fair-value range."}, {"label": "Latest direct headline", "value": "Positive", "tone": "positive", "text": "Jagsonpal Pharma rallies 14% on acquisition update; time to book profit?"}], "updated_at": "2026-07-17T07:27:51.672022+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}